Filing Flows

Filing Flows › Industrials › Exponent (EXPO)

Exponent (EXPO) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 6, 2026 · Exponent (EXPO) Q3 2026 earnings results →

Q3 2026 Revenue up 18% year over year to $174M · 18¢ of every $1 of revenue kept as net profit · operating margin 24.1%

Exponent made $174M in Q3 2026 (+18% Y/Y). Operating margin 24.1%, net earnings $30.9M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 6, 2026.

Revenue$174M
Year over year+18%
Operating margin24.1%
Net earnings$30.9M
Operating cash flow$63.2M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $173.7M in Q3 2026, up 18% year over year and up 1% from the previous quarter.

Operating profit was $41.9M, a 24.1% margin (up 4.4 points year over year). Of the extra revenue versus Q3 2025, 48% reached operating profit, above the 20% margin then. Total costs grew 12% against revenue growth of 18%. The fastest-growing cost line was Other operating costs (+13%). Net earnings were $30.9M, up 10% year over year. The effective tax rate was 28.0%.

Operating cash flow was $63.2M (up 94% year over year), 204% of net earnings. Non-cash charges added back $2.7M of depreciation and amortization and $6.7M of share-based compensation. Working capital and other items added $22.9M. Capital expenditures of $1.2M left free cash flow of $62.1M.

Quarterly history

Exponent revenue by quarterExponent revenue by quarter$146MQ1 2025$142MQ2 2025$147MQ3 2025$147MQ4 2025$166MQ1 2026$172MQ2 2026$174MQ3 2026
Exponent net earnings by quarterExponent net earnings by quarter$26.6MQ1 2025$26.6MQ2 2025$28.0MQ3 2025$24.8MQ4 2025$29.6MQ1 2026$29.4MQ2 2026$30.9MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 6, 2026$174M+18%24.1%$30.9M$63.2M
Q2 202610-QAug 7, 2026$172M+21%16.3%$29.4M$30.9M
Q1 202610-QMay 8, 2026$166M+14%24.9%$29.6M−$975K
Q4 202510-KFeb 27, 2026$147M+8%19.8%$24.8M$55.6M
Q3 202510-QNov 7, 2025$147M+8%19.7%$28.0M$32.7M
Q2 202510-QAug 8, 2025$142M+1%12.1%$26.6M$36.2M
Q1 202510-QMay 9, 2025$146M+0.4%30.5%$26.6M$7.3M

Charts

Exponent: revenue growth, year over year and quarter over quarterExponent: revenue growth, year over year and quarter over quarterY/YQ/Q+0%Q1 2025+1%-2%Q2 2025+8%+4%Q3 2025+8%+0%Q4 2025+14%+13%Q1 2026+21%+3%Q2 2026+18%+1%Q3 2026
Latest (Q3 2026): Y/Y +18%, Q/Q +1%.
Exponent: where the cash came from (+) and went (−), TTM to Q3 2026Exponent: where the cash came from (+) and went (−), TTM to Q3 2026Buybacks−$171MOperating cash flow$149MCash drawn (+) / kept (−)$92.7MDividends−$61.0MCapital spending−$8.1MTaxes on employees’ shares−$5.1MShares issued$3.5MExchange rates−$222K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Exponent: profit against cash, quarter by quarterExponent: profit against cash, quarter by quarterNet incomeOperating cash flow$23.6M$56.1MQ4 2024$26.6M$7.3MQ1 2025$26.6M$36.2MQ2 2025$28.0M$32.7MQ3 2025$24.8M$55.6MQ4 2025$29.6M−$975KQ1 2026$29.4M$30.9MQ2 2026$30.9M$63.2MQ3 2026
Latest (Q3 2026): Net income $30.9M, Operating cash flow $63.2M.
Exponent: diluted shares by fiscal yearExponent: diluted shares by fiscal year53MFY202053MFY202152MFY202252MFY202352MFY202451MFY2025
-3.9% since FY2020: buybacks shrank the count.
Exponent in its industry: growth against margin (30 companies, SIC 8742)Exponent in its industry: growth against margin (30 companies, SIC 8742)revenue growth, year over year →↑ operating marginmedian +4%median 2%BAHGASTHFCNHURNICFIONTRMRBWMNHCKTIIIPPHCTSSIMHHAERTCTMCISOACCSPBSVRTBLBRAEUBGELVGGRNQHapi Metaverse Inc.RDSCYSGLCybriatech IncLEENEXPO (+18%, 24%)
Services-Management Consulting Services; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world. Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, and integrated technical platform work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward at speed.

In its own words, from its 8-K, filed Jul 30, 2026.

Exponent against its Services-Management Consulting Services peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +18% against the peers' median +6%. Operating margin: 24.1% against the peers' median 8.9%.

CompanyQuarterRevenueY/YOp. margin
EXPO ExponentQ3 2026$174M+18%24.1%
BAH Booz Allen Hamilton HoldingQ2 FY27$2.8B-4%8.8%
G GenpactQ3 2026$1.4B+7%15.2%
ASTH Astrana HealthQ3 2026$1.0B+7%3.9%
FCN FTI ConsultingQ3 2026$1.0B+6%8.9%
HURN Huron Consulting GroupQ3 2026$491M+11%12.0%
ICFI ICF InternationalQ3 2026$470M+1%9.3%
ONT OnterrisQ3 2026$203M-10%6.0%
RMR RMR GroupQ3 FY26$154M-0.8%-6.0%

Source: Exponent 10-Q on SEC EDGAR · CIK 851520 · Services-Management Consulting Services

Guidance and outlook

Exponent: what its forward-looking statements are about (10-Q filed 2026-11-06)Exponent: what its forward-looking statements are about (10-Q filed 2026-11-06)Costs4Other3Capital spending1
8 statements; tone +0.62 (−1 all cautious, +1 all confident); 1 hedged.
Exponent: outlook statements against the filing beforeExponent: outlook statements against the filing beforeConfident5

13F: who owns EXPO and who is buying

Largest holders of EXPO (13F)Largest holders of EXPO (13F)BlackRock$363MVanguard Group$357MKayne Anderson Rudnick Investment…$235MVanguard Portfolio Management LLC$185MVanguard Capital Management LLC$128MState Street$114MGeode Capital Management, LLC$103MGeneva Capital Management LLC$82.6MRoyce & Associates LP$77.7MMorgan Stanley$71.3M
Funds' net buying of EXPO by quarter (13F)Funds' net buying of EXPO by quarter (13F)−$9.0M2024-09−$10.2M2024-12$22.0M2025-03$134M2025-06−$85.2M2025-09$460K2025-12$23.5M2026-03−$101M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on EXPO

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare EXPO with

中文版:Exponent(EXPO)财报

Español · Français